CTRI/2016/11/007450尚未招募未知
A randomized controlled trial to evaluate the effect of low dose atropine eyedrop for childhood myopia
Dr Rajendra Prasad Centre for Ophthalmic Science0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age 6-12 years
- •Refractive error of spherical equivalent between -2D to -6D in each eye as measured by cycloplegic autorefraction
- •Distance vision correctable to logMAR 0.2 or better in both eyes
- •Normal ocular health other than myopia
- •Informed consent
- •Willing to follow-up
排除标准
- •Astigmatism more than -1.5 D as measured by cycloplegic autorefraction
- •Allergy to atropine or homatropine
- •Previous or concurrent use of contact lenses, bifocals, progressive addition lenses or other forms of treatment (including atropine) for myopia
- •History of cardiac , neurologic or significant respiratory diseases.
- •Unwilling to give consent/ follow-up
研究者
相似试验
已完成
不适用
A randomized controlled trial to evaluate the effectiveness of adjuvant chemotherapy using FOLFOX to prevent recurrence after curative radiofrequency ablation of liver metastasis from colorectal carcinomaCases with liver metastasis from colorectal carcinoma, which is removed curatively by radiofrequency ablationJPRN-C000000360Department of gastroenterology, Tokyo University Hospital190
尚未招募
不适用
A study to evaluate the effect of surgical technique in seroma formation in breast cancer surgery-dissection by electrocautery vs scissorsCTRI/2021/11/037708AIIMS Nagpur
已完成
不适用
To find out which method of pain management is effective during bracket removal.CTRI/2020/08/027272Dr Sanjay Prasad Gupta
已完成
不适用
A randomized controlled trial to evaluate the effectiveness of personalized genetic breast cancer risk feedback for non-breast cancer womeBreast cancer prevention behaviorJPRN-UMIN000026768Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute200
尚未招募
不适用
A randomized controlled trial to evaluate the effectiveness of capecitabine as a postoperative adjuvant regimen in inhibiting the recurrence of intrahepatic cholangiocarcinoma after curative resectiointrahepatic cholangiocellular carcinomaCancer - Biliary tree (gall bladder and bile duct)ACTRN12613000519752The Eastern Hepatobiliary Surgery Hospital120